Delivra Health Brands' Dream Water(R) Brand Drives Growth with Launch of 6-Count Sleep Gummies into the Canadian Market
Delivra Health Brands (TSXV: DHB) (OTCQB: DHBUF) has announced the launch of Dream Water® 6-Count Sleep Gummies in the Canadian market. This new product follows the successful introduction of their 60-count Dream Water® Gummies in February 2024.
The 6-Count Sleep Gummies will be available to distributors, retailers, and e-commerce channels in March 2025. According to CEO Gord Davey, this strategic launch aims to capture growth opportunities in the travel and convenience retail channels while strengthening the company's position in sleep solutions.
The product will be distributed nationwide through Delivra Health's established retail and e-commerce partners, building on the momentum of Dream Water Sleep Gummies in both Canadian and US markets.
Delivra Health Brands (TSXV: DHB) (OTCQB: DHBUF) ha annunciato il lancio di Dream Water® 6-Count Sleep Gummies nel mercato canadese. Questo nuovo prodotto segue l'introduzione di successo delle loro gomme da masticare Dream Water® da 60 conteggi nel febbraio 2024.
Le gomme da masticare per il sonno da 6 conteggi saranno disponibili per distributori, rivenditori e canali di e-commerce a partire da marzo 2025. Secondo il CEO Gord Davey, questo lancio strategico mira a cogliere opportunità di crescita nei canali di vendita al dettaglio per viaggi e comodità, rafforzando al contempo la posizione dell'azienda nelle soluzioni per il sonno.
Il prodotto sarà distribuito a livello nazionale attraverso i partner di vendita al dettaglio e di e-commerce consolidati di Delivra Health, costruendo sul slancio delle gomme da masticare Dream Water Sleep sia nel mercato canadese che in quello statunitense.
Delivra Health Brands (TSXV: DHB) (OTCQB: DHBUF) ha anunciado el lanzamiento de Dream Water® 6-Count Sleep Gummies en el mercado canadiense. Este nuevo producto sigue la exitosa introducción de sus gomitas Dream Water® de 60 conteos en febrero de 2024.
Las gomitas para dormir de 6 conteos estarán disponibles para distribuidores, minoristas y canales de comercio electrónico en marzo de 2025. Según el CEO Gord Davey, este lanzamiento estratégico tiene como objetivo captar oportunidades de crecimiento en los canales de venta al por menor de viajes y conveniencia, al mismo tiempo que fortalece la posición de la empresa en soluciones para el sueño.
El producto será distribuido a nivel nacional a través de los socios de venta al por menor y comercio electrónico establecidos de Delivra Health, aprovechando el impulso de las gomitas para dormir Dream Water tanto en los mercados canadiense como estadounidense.
Delivra Health Brands (TSXV: DHB) (OTCQB: DHBUF)는 캐나다 시장에 Dream Water® 6-Count Sleep Gummies를 출시한다고 발표했습니다. 이 새로운 제품은 2024년 2월에 60개입 Dream Water® Gummies의 성공적인 도입에 이어 출시됩니다.
6개입 수면 젤리는 2025년 3월부터 유통업체, 소매업체 및 전자상거래 채널에서 제공됩니다. CEO Gord Davey에 따르면, 이 전략적 출시는 여행 및 편의점 소매 채널에서 성장 기회를 포착하고, 수면 솔루션에서 회사의 입지를 강화하는 것을 목표로 하고 있습니다.
이 제품은 Delivra Health의 기존 소매 및 전자상거래 파트너를 통해 전국적으로 유통되며, 캐나다 및 미국 시장에서 Dream Water Sleep Gummies의 모멘텀을 기반으로 합니다.
Delivra Health Brands (TSXV: DHB) (OTCQB: DHBUF) a annoncé le lancement de Dream Water® 6-Count Sleep Gummies sur le marché canadien. Ce nouveau produit fait suite à l'introduction réussie de leurs gummies Dream Water® de 60 unités en février 2024.
Les gummies de sommeil de 6 unités seront disponibles pour les distributeurs, les détaillants et les canaux de commerce électronique à partir de mars 2025. Selon le PDG Gord Davey, ce lancement stratégique vise à saisir des opportunités de croissance dans les canaux de vente au détail de voyage et de commodité, tout en renforçant la position de l'entreprise dans les solutions de sommeil.
Le produit sera distribué à l'échelle nationale par le biais des partenaires de vente au détail et de commerce électronique établis de Delivra Health, s'appuyant sur l'élan des gummies de sommeil Dream Water sur les marchés canadien et américain.
Delivra Health Brands (TSXV: DHB) (OTCQB: DHBUF) hat den Launch von Dream Water® 6-Count Sleep Gummies auf dem kanadischen Markt angekündigt. Dieses neue Produkt folgt auf die erfolgreiche Einführung ihrer 60-count Dream Water® Gummies im Februar 2024.
Die 6-Count Sleep Gummies werden ab März 2025 für Distributoren, Einzelhändler und E-Commerce-Kanäle erhältlich sein. Laut CEO Gord Davey zielt dieser strategische Launch darauf ab, Wachstumschancen im Reise- und Convenience-Einzelhandel zu nutzen und gleichzeitig die Position des Unternehmens im Bereich Schlaflösungen zu stärken.
Das Produkt wird landesweit über die etablierten Einzelhandels- und E-Commerce-Partner von Delivra Health verteilt und baut auf dem Schwung der Dream Water Sleep Gummies sowohl im kanadischen als auch im US-Markt auf.
- Product line expansion with new 6-Count Sleep Gummies format
- Strategic entry into travel and convenience retail channels
- Building on successful momentum of existing 60-count product
- None.
Vancouver, British Columbia--(Newsfile Corp. - March 12, 2025) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce that its Dream Water® brand is launching its new 6-Count Sleep Gummies in the Canadian market. This product launch builds on the strong market performance of the Company's 60-count Dream Water® Gummies launched in Canada in February 2024. 6-Count Sleep Gummies are expected to be available to Company distributors, retailers and e-commerce channels in March 2025.
"This strategic product launch is designed to further capture growth opportunities within the travel and convenience retail channels and strengthen the Company's market position as the consumer choice of sleep solutions," said Gord Davey, President and Chief Executive Officer of Delivra Health. "The launch of these 6-Count Gummies capitalizes on the momentum of Dream Water Sleep Gummies in both the Canadian and US markets. The new product will be made available nationwide through Delivra Health's established retail and e-commerce distribution partners."
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/2413/244223_34c14e3b54affa47_001full.jpg
About Delivra Health Brands Inc.
Helping people take control of their health with alternative wellness solutions is what energizes the Delivra Health team! The Delivra Health portfolio features innovative brands like Dream Water® and LivRelief™, which deliver relief from common everyday issues like chronic pain, anxiety, and sleeplessness. Delivra Health products have allowed millions of customers to reclaim their mobility, energy, and in turn, quality of life. The websites of the Company's two subsidiaries are Dream Water® and LivReliefTM. For more information, please visit www.delivrahealthbrands.com.
Cautionary Note Regarding Forward-Looking Statements
This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates, and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements include, among other things, statements with respect to timing of the availability of the 6-Count Sleep Gummies, the Company's growth opportunities in new and existing markets, and distribution channels for the 6-Count Sleep Gummies.
These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the cannabis markets where the Company operates; changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; employee relations and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution; and sale of cannabis and cannabis-related products in the markets where the Company operates. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.
Additional information regarding this and other risks and uncertainties relating to the Company's business are contained under the heading "Risk Factors" in the Company's annual information form dated March 2, 2021, and under the heading "Risks and Uncertainties" in the Q2 2025 MD&A filed under the Company's profile on SEDAR+ at www.sedarplus.ca.
Neither TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accept responsibility for the adequacy or accuracy of this release.
Investor Relations:
Jack Tasse
Chief Financial Officer
IR@delivrahealth.com
1-877-915-7934
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/244223